Plunkett Research Online: Repros Therapeutics Inc

REPROS THERAPEUTICS INC (Subsidiary) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Repros Therapeutics, Inc. develops drugs for the treatment of reproductive and hormonal system disorders. The firm’s lead product candidate is Proellex, a selective progesterone receptor blocker for the treatment of uterine fibroids and the treatment of endometriosis in women. The National Uterine.....


REPROS THERAPEUTICS INC

Ticker: Subsidiary
Exchange:
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 281 719-3400
Fax: 281 719-3446
Address: 2408 Timberloch Place, Ste. B-7
The Woodlands, TX 77380 United States

Types Of Business
Industry Ranks

Industry NAICS code:
Parent Company: Allergan plc

ContactsDescription

Larry DillahaCEO/Pres.
Maria HiladoDirector
See More
Repros Therapeutics, Inc. develops drugs for the treatment of reproductive and hormonal system disorders. The firm’s lead product candidate is Proellex, a selective progesterone receptor blocker for the treatment of uterine fibroids and the treatment of endometriosis in women. The National Uterine.....See More See More

$USD, In whole numbers 2017201620152014201320122011
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture